Colorectal cancer (CRC) is considered as the second most common cancer worldwide. For
the past few years, the role of immunotherapy has been extensively studied and it has been …

The advent of iPSCs has brought about a significant transformation in stem cell research,
opening up promising avenues for advancing cancer treatment. The formation of cancer is a …

Colorectal cancer (CRC) is a leading cause of morbidity and mortality worldwide. The
majority of CRC deaths are caused by tumor metastasis, even following treatment. There is …

Aim This study aimed to investigate the prevalence and any potential association between
Epstein-Barr virus (EBV) infection and colorectal cancer (CRC). Methods A systematic …

Although the outcome of colorectal cancer (CRC) patients has improved significantly with
the recent implementation of annual screening programs, reliable prognostic biomarkers are …

Colorectal cancer (CRC) is the third most prevalent cancer in the world. Globally, it has been
estimated that about 1.4 million new cases of colorectal cancer are diagnosed every year …

Although developments in the diagnosis and therapy of colorectal cancer (CRC) have been
made in the last decade, much work remains to be done as it remains the second leading …

Background Colorectal cancer (CRC) is a leading cause of cancer-related deaths
worldwide. Early detection of CRC can significantly reduce its mortality rate. Current method …

A cancer cell is the final product of a complex mixture of genetic, epigenetic and
epitranscriptomic alterations, whose final interplay contribute to cancer onset and …

Colorectal cancer (CRC) is the third most diagnosed cancer in the western world, affecting 1
out of approximately 22 people in their lifetime. Several epidemiological studies suggest a …